Analystreport

Blueprint Medicines Corporation (NASDAQ: BPMC) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com